Fed. Circ. Kills 2 Patents On Horizon Pain Drug Vimovo
The Federal Circuit ruled Wednesday that two patents on Horizon Pharma's pain reliever Vimovo are invalid, backing generics makers and reversing a lower court decision that upheld the patents on a...To view the full article, register now.
Already a subscriber? Click here to view full article